基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Professor Lalvani’s research programme addresses the world’s most serious respiratory infections: tuberculosis and pandemic influenza. His research has been published in over 120 scholarly articles and book chapters, with over 8,000 citations in the medical and scientific literature.CLINICAL AND PUBLIC HEALTH IMPACTClinical Practice: Professor Lalvani’s first translational research output, IGRA (T-SPOT.TB™) transformed clinical practice, shaped TB control policy internationally and provided health services with CDC and EuroCDC-endorsed rapid tools to cost-effectively deliver a TB elimination strategy through targeted preventative therapy of latent TB. Deployment of IGRA prevents diagnostic delays and unnecessary overtreatment - and is much preferred by patients.Policy and Guidelines: Having created the evidence-base underpinning the national and European guidelines endorsing IGRA (2006-2010), Professor Lalvani’s went on to develop a new evidence-based NICE-endorsed policy (2011) for immigrant TB screening which has set the new national clinical agenda on tackling TB in the EU.
Research Interests
Papers共 292 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
biorxiv(2024)
Dana Costigan,Joe Fenn,Sandi Yen,Nicholas Ilott,Samuel Bullers,Jessica Hale,William Greenhalf,Emily Conibear,Aleksandra Koycheva,Kieran Madon, Ishrat Jahan, Ming Huang,
Mucosal immunologyno. 1 (2024): 111-123
MICROBIOLOGY SPECTRUMno. 4 (2024): e0363423-e0363423
The Lancet. Microbeno. 6 (2023): e397-e408
Journal of infection and public healthno. 5 (2023): 660-672
BIOINFORMATICSno. 11 (2023)
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Bioinform.no. 10 (2023)
Load More
Author Statistics
#Papers: 281
#Citation: 19213
H-Index: 68
G-Index: 135
Sociability: 7
Diversity: 3
Activity: 43
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn